cadenas

ITCC-051 COMIBETINIB

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-051 COMIBETINIB

A Phase I/II, Multicenter, Open-Label, dose‑escalation Study of the Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Patients with Previously treated Solid Tumors

Promotor Name : HOFFMAN LA ROCHE

Investigator Name : B. GEOERGER

Trial registered on clinicaltrial.gov: NCT02639546